Journal
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY
Volume 6, Issue 6, Pages 532-547Publisher
WILEY
DOI: 10.1002/wnan.1282
Keywords
-
Funding
- National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK095168]
Ask authors/readers for more resources
Despite the wide success of antibiotics, the treatment of bacterial infections still faces significant challenges, particularly the emergence of antibiotic resistance. As a result, nanoparticle drug delivery platforms including liposomes, polymeric nanoparticles, dendrimers, and various inorganic nanoparticles have been increasingly exploited to enhance the therapeutic effectiveness of existing antibiotics. This review focuses on areas where nanoparticle approaches hold significant potential to advance the treatment of bacterial infections. These areas include targeted antibiotic delivery, environmentally responsive antibiotic delivery, combinatorial antibiotic delivery, nanoparticle-enabled antibacterial vaccination, and nanoparticle-based bacterial detection. In each area we highlight the innovative antimicrobial nanoparticle platforms and review their progress made against bacterial infections. WIREs Nanomed Nanobiotechnol 2014, 6:532-547. doi: 10.1002/wnan.1282 For further resources related to this article, please visit the . Conflict of interest: The authors have declared no conflicts of interest for this article.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available